Christopher Poole
- Internal Medicine top 0.5%
- Cancer Research top 2%
- Breast Cancer Treatment Studies 19
- Cancer Genomics and Diagnostics 8
- Oncology top 1%
- Cancer Treatment and Pharmacology 16
- HER2/EGFR in Cancer Research 7
- PARP inhibition in cancer therapy 6
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 14
- Emergency Medical Services top 1%
-
- Advanced Breast Cancer Therapies 8
-
- BRCA gene mutations in cancer 7
Christopher Poole
64 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Internal Medicine 832
- Cancer Research 994
- Oncology 1.7k
- Reproductive Medicine 451
- Emergency Medical Services 279
Countries citing papers authored by Christopher Poole
This map shows the geographic impact of Christopher Poole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Poole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Poole more than expected).
Fields of papers citing papers by Christopher Poole
This network shows the impact of papers produced by Christopher Poole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Poole. The network helps show where Christopher Poole may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher Poole, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2019 | 10 | |
| 3 | Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)breakdown → | 2018 | 855 |
| 4 | 2018 | 142 | |
| 5 | 2016 | 55 | |
| 6 | 2016 | 8 | |
| 7 | 2014 | 82 | |
| 8 | 2013 | 13 | |
| 9 | 2012 | 115 | |
| 10 | 2011 | 23 | |
| 11 | 2011 | 31 | |
| 12 | 2003 | 41 | |
| 13 | 2003 | 7 | |
| 14 | 2002 | 100 | |
| 15 | 2002 | 54 | |
| 16 | 2000 | 34 | |
| 17 | 2000 | 2 | |
| 18 | 2000 | 2 | |
| 19 | 1998 | 15 | |
| 20 | 1996 | 128 |
About Christopher Poole
Christopher Poole is a scholar working on Cancer Research, Reproductive Medicine and Oncology, having authored 65 papers that have together received 3.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (19 papers), Cancer Treatment and Pharmacology (16 papers), Ovarian cancer diagnosis and treatment (14 papers), Cancer Genomics and Diagnostics (8 papers), Advanced Breast Cancer Therapies (8 papers), BRCA gene mutations in cancer (7 papers), HER2/EGFR in Cancer Research (7 papers) and PARP inhibition in cancer therapy (6 papers). The work is most often cited by research in Internal Medicine (832 citations), Cancer Research (994 citations) and Oncology (1.7k citations). Christopher Poole has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Janet Dunn, Annie Young, Andrea Marshall, Oliver Chapman, Ajay K. Kakkar, Helena Earl, Mark N. Levine, Charles Hutchinson, Anand Lokare and Gary H. Lyman. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Cancer Chemotherapy and Pharmacology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.